Cargando…
Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214199/ https://www.ncbi.nlm.nih.gov/pubmed/37186868 http://dx.doi.org/10.1073/pnas.2306087120 |
_version_ | 1785047787924094976 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10214199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-102141992023-05-27 Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target Proc Natl Acad Sci U S A Correction National Academy of Sciences 2023-05-15 2023-05-23 /pmc/articles/PMC10214199/ /pubmed/37186868 http://dx.doi.org/10.1073/pnas.2306087120 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Correction Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title | Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title_full | Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title_fullStr | Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title_full_unstemmed | Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title_short | Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target |
title_sort | correction for zhou et al., dysregulation of pd-l1 by ufmylation imparts tumor immune evasion and identified as a potential therapeutic target |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214199/ https://www.ncbi.nlm.nih.gov/pubmed/37186868 http://dx.doi.org/10.1073/pnas.2306087120 |